MediCane Health Inc. Announce First Patient Enrolled in a Phase IIa Clinical Trial of MediCane’s Balanced T3:C3 Oral Medical Cannabis Oil for Symptom Relief of Behavioral and Psychological Symptoms of Dementia (BPSD)
KFAR SAVA, Israel--(BUSINESS WIRE)--MediCane Health Inc. (along with its subsidiaries together referred to as "MediCane")…